Cancer Research and Treatment10.4143/crt.2018.0792019511280-288Different Patterns of Risk Reducing Decisions in Affected or Unaffected BRCA Pathogenic Variant CarriersEun-Gyeong Lee, Hyok Jo Kang, Myong Cheol Lim, Boyoung Park, Soo Jin Park, So-Youn Jung, Seeyoun Lee, Han-Sung Kang, Sang-Yoon Park, Boram Park, Jungnam Joo, Jai Hong Han, Sun-Young Kong, Eun Sook Lee,,
Ob.Gyn. News10.1016/s0029-7437(08)70008-920084326Lifetime Ca Risk Is High in Unaffected BRCA CarriersBRUCE JANCIN,
Familial Cancer10.1007/s10689-019-00142-82019184377-379Should unaffected female BRCA2 pathogenic variant carriers be told there is little or no advantage from risk reducing mastectomy?D. Gareth Evans, Sacha J. Howell, Anthony Howell,,
Family Practice News10.1016/s0300-7073(08)70081-120083824Lifetime Cancer Risk Is High In Unaffected BRCA CarriersBRUCE JANCIN,
Managing BRCA Mutation Carriers10.1007/978-3-319-59198-8_4201747-63Risk-Reducing Surgery for BRCA1/2 Genetic Mutation CarriersCristina O’Donoghue, Sonia Orcutt, Tuya Pal, Christine Laronga
Clinical Genetics10.1111/j.1399-0004.2009.01329.x2010774342-349Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timingA-B Skytte, A-M Gerdes, MK Andersen, L Sunde, K Brøndum-Nielsen, M Waldstrøm, S Kølvraa, D Crüger,
Maturitas10.1016/j.maturitas.2010.08.0092010673290Risk-reducing salpingo-oophorectomy for BRCA mutation carriersKrishnayan Haldar, Robin Crawford,
European Journal of Surgical Oncology10.1016/j.ejso.2020.03.0552020466e15P016: Development of a decision aid toolkit to support BRCA mutation carriers who are unaffected by cancer and are considering risk reducing optionsYvonne Hanhauser, Anne Marie Brady, Niamh Byrne, Elizabeth Connolly,
Gynecologic Oncology10.1016/j.ygyno.2013.04.30620131301e104-e105Patterns of care for risk-reducing salpingo-oophorectomy (RRSO) for BRCA mutation carriers and subsequent surveillanceI. Cass, C. Walsh, J. Lester, A. Li, B. Karlan,
Gynecologic Oncology10.1016/j.ygyno.2020.05.4612020159265-266Patterns of care for risk reducing surgery in non-BRCA and Lynch ovarian cancer susceptibility mutation carriersZ.P. Schwartz, A.J. Li, C. Walsh, B.J. Rimel, M.M. Alvarado, S.E. Lentz, I. Cass,